In the case of sarcomas, it has been shown that GLI1 and GLI2 can be overexpressed in various types of sarcomas, both in bone (osteosarcomas) and soft tissue (rhabdomyosarcomas) [148,149,150]. This evidence concerns the gene GLI1 and rhabdomyosarcoma.